Anna M Johnston

6PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.

|Jan 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review.

Luke Wang, Eliza Chung, Cameron Wellard

|Apr 09, 2024
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.

Zoe K McQuilten, Robert Weinkove, Le Thi Phuong Thao

|Mar 14, 2024
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies.

Sara Carrillo de Albornoz, Alisa M Higgins, Dennis Petrie

|Apr 17, 2023
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma.

Nancy L Bartlett, Sarit Assouline, Pratyush Giri

|Dec 20, 2022
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.

James Nguyen, Cameron Wellard, Eliza Chung

Pageof 1

Frequent Collaborators

4 joint publications

Zoe K McQuilten

4 joint publications

Erica M Wood

3 joint publications

Cameron Wellard

3 joint publications

Judith Trotman